Literature DB >> 19925615

Defining sarcopenia in terms of risk of physical limitations: a 5-year follow-up study of 3,153 chinese men and women.

Jean Woo1, Jason Leung, Aprille Sham, Timothy Kwok.   

Abstract

OBJECTIVES: To examine the definition of sarcopenia in Chinese subjects by relating the value of appendicular skeletal muscle mass (ASM) divided by height squared to physical functional outcomes after 4 years.
DESIGN: Four-year prospective study.
SETTING: A Chinese community in Hong Kong SAR China. PARTICIPANTS: Three thousand one hundred fifty-three community-living men and women aged 65 and older.
METHODS: Information collected by questionnaire included demographics, health limitation on activities of daily living (ADLs), self-care, physical activity level, dietary intake, and psychosocial functioning. Measurements included height, weight, grip strength, step length in a 6-minute walk, and body composition. Four-year outcomes for those with ASM in kg per height in meters squared (ASM/ht(2)) less than 2 standard deviations (SDs) and 2 SDs or more below the young adult mean value were compared using analysis of variance and logistic regression, adjusting for potential confounding factors such as age, fat mass, presence or absence of malnutrition, dietary protein and vitamin D intake, comorbidity, and cognitive impairment.
RESULTS: Participants with ASM/ht(2) 2 SDs or more below the young adult mean had lower grip strength and greater limitation in climbing stairs and general ADLs after adjusting for confounding factors. A U-shaped relationship was observed between physical limitation and ASM/ht(2), with increasing physical limitation below or above a range of 7.25 to 6.75 kg/m(2) in men and 6.00 to 6.25 kg/m(2) in women. Values of 5.25 to 6.74 kg/m(2) in women were associated with approximately 30% less risk of functional limitation after 5 years. No clear cutoff was found in men.
CONCLUSION: Sarcopenia may be defined in terms of a range of values for ASM/ht(2) associated with the lowest risk of future physical limitations. The importance of establishing a quantitative value for the definition of sarcopenia may facilitate future interventional studies using pharmacological or nonpharmacological strategies.

Entities:  

Mesh:

Year:  2009        PMID: 19925615     DOI: 10.1111/j.1532-5415.2009.02566.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  35 in total

1.  Limitations to exercise in female centenarians: evidence that muscular efficiency tempers the impact of failing lungs.

Authors:  Massimo Venturelli; Federico Schena; Renato Scarsini; Ettore Muti; Russell S Richardson
Journal:  Age (Dordr)       Date:  2012-01-15

2.  Strength measures are better than muscle mass measures in predicting health-related outcomes in older people: time to abandon the term sarcopenia?

Authors:  J C Menant; F Weber; J Lo; D L Sturnieks; J C Close; P S Sachdev; H Brodaty; S R Lord
Journal:  Osteoporos Int       Date:  2016-07-09       Impact factor: 4.507

3.  Diagnostic criteria for sarcopenia and physical performance.

Authors:  A Y Bijlsma; C G M Meskers; N van den Eshof; R G Westendorp; S Sipilä; L Stenroth; E Sillanpää; J S McPhee; D A Jones; M V Narici; H Gapeyeva; M Pääsuke; T Voit; Y Barnouin; J Y Hogrel; G Butler-Browne; A B Maier
Journal:  Age (Dordr)       Date:  2013-07-02

4.  Adiposity to muscle ratio predicts incident physical limitation in a cohort of 3,153 older adults--an alternative measurement of sarcopenia and sarcopenic obesity.

Authors:  Tung Wai Auyeung; Jenny Shun Wah Lee; Jason Leung; Timothy Kwok; Jean Woo
Journal:  Age (Dordr)       Date:  2012-05-22

Review 5.  Selecting Potential Pharmacological Interventions in Sarcopenia.

Authors:  Amanda J Kilsby; Avan A Sayer; Miles D Witham
Journal:  Drugs Aging       Date:  2017-04       Impact factor: 3.923

6.  Thigh muscle volume predicted by anthropometric measurements and correlated with physical function in the older adults.

Authors:  B B Chen; T T F Shih; C Y Hsu; C W Yu; S Y Wei; C Y Chen; C H Wu; C Y Chen
Journal:  J Nutr Health Aging       Date:  2011-06       Impact factor: 4.075

7.  Are current definitions of sarcopenia applicable for older Chinese adults?

Authors:  X Wen; M Wang; C-M Jiang; Y-M Zhang
Journal:  J Nutr Health Aging       Date:  2011-12       Impact factor: 4.075

8.  Effect of Antihypertensive and Statin Medication Use on Muscle Performance in Community-Dwelling Older Adults Performing Strength Training.

Authors:  Mohammad Alturki; Keliane Liberman; Andreas Delaere; Liza De Dobbeleer; Veerle Knoop; Tony Mets; Siddhartha Lieten; Bert Bravenboer; Ingo Beyer; Ivan Bautmans
Journal:  Drugs Aging       Date:  2021-02-05       Impact factor: 3.923

9.  Comparisons of sarcopenia prevalence based on different diagnostic criteria in Chinese older adults.

Authors:  X Wen; P An; W C Chen; Y Lv; Q Fu
Journal:  J Nutr Health Aging       Date:  2015-03       Impact factor: 4.075

10.  Multi-morbidity, dependency, and frailty singly or in combination have different impact on health outcomes.

Authors:  Jean Woo; Jason Leung
Journal:  Age (Dordr)       Date:  2013-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.